PRIMAEGISresearch
← Scenarios
AARTIDRUGS

Aarti Drugs Limited

Pharmaceuticals: Major/ NSE
Compiled

Auto-generated from filings and public channels — no analyst dossier.

If management delivers what it guided

arithmetic on filed guidance and past valuations · not a price target
AARTIDRUGS
FY26 → FY27 · 1 year of guidance · ~0.7 years from today₹423 today
BEAR
₹363
-14%
6% a year · 16x exit
BASE
₹439
+4%
10.4% a year · 18.6x exit
BULL
₹562
+33%
14.1% a year · 23.1x exit
FY27TODAY₹423 today₹562₹363₹439
Where the market has priced it
9x20x today25x
  • the guided figure reached earnings through a low-confidence bridge
  • FY27 one quarter filed — the pace is shown, not judged: guided +8.0%, filed +19.0% across 1 quarter(s)
  • this company's own median multiple sits 38% below its filed-industry peers; the scenario uses its own
How these numbers are produced
Earnings baseFY26 fiscal year EPS ₹21.36 (screener)
Guided growth10.4% a year, said on the call of 23-May-2026 · transcript
Read across asoperating: volume growth, realisation+margin held flat — low confidence
Delivery calibration0.58x / 1x / 1.36x of what was guided — measured: 76 annual guided-vs-filed pairs + 77 near-complete quarterly years — NSE transcripts against the companies' own filings
Exit multiple16x / 18.64x / 23.08x, this company’s own p20 / median / p80 across 10 filed years
Filed-industry peersmedian 30.27x across 38 peers — the cross-check, not the input
Arithmeticbase EPS × (1 + guided growth × delivery)1 × exit multiple
Arithmetic on management’s own guidance and this company’s own past valuations. Not a price target, not a recommendation, and not a forecast of what the stock will do.

What management said

from NSE earnings-call filings · extracted, not interpreted
volume growth 10%generic growth 8%ebitda margin 14.5%
So, with that, if we are talking about 8% to 10% volume growth, does it mean the existing base business, there we are not expecting much of a volume growth because that sounds slightly on the lower end, right, with the new capacity on so ma
Call 23-May-2026 · bridge confidence low · transcript PDF

Pace against its own guidance

FY27 one quarter filed — the pace is shown, not judged
guided 8.0% filed 19.0% 1 of 4 quarters